0001493152-18-001037.txt : 20180125 0001493152-18-001037.hdr.sgml : 20180125 20180125150309 ACCESSION NUMBER: 0001493152-18-001037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180123 FILED AS OF DATE: 20180125 DATE AS OF CHANGE: 20180125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Diaz-Mitoma Francisco CENTRAL INDEX KEY: 0001701865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37769 FILM NUMBER: 18548051 MAIL ADDRESS: STREET 1: 222 THIRD STREET, SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VBI Vaccines Inc/BC CENTRAL INDEX KEY: 0000764195 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-830-3031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: SciVac Therapeutics Inc. DATE OF NAME CHANGE: 20150717 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD. DATE OF NAME CHANGE: 20100910 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD DATE OF NAME CHANGE: 19850305 4 1 form4.xml X0306 4 2018-01-23 0 0000764195 VBI Vaccines Inc/BC VBIV 0001701865 Diaz-Mitoma Francisco C/O VBI VACCINES INC., 222 THIRD STREET, STE 2241 CAMBRIDGE, MA 02142 0 1 0 0 Chief Medical Officer Option (Right to Buy Common Shares) 4.255 2018-01-23 4 A 0 100000 0 A 2028-01-23 Common Shares 100000 100000 D Exercise price is in Canadian dollars. United States dollars equivalent is shown using the closing foreign exchange rate on the Grant Date (as defined below). The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the "Option Agreement"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date. The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement. /s/ Francisco Diaz-Mitoma 2018-01-25